Nuclear factor-kappa B (NF-ΚB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases

Nutraceuticals are dietary supplements that are used to improve health, postpone aging, prevent illnesses, and maintain the human body's correct functioning. Nutraceuticals are now garnering a lot of interest because of their nutritional and therapeutic benefits. The research indicating the relevance of nutraceuticals as a possible therapeutic candidate against inflammatory lung disease was covered in this review. Nowadays, inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, asthma, pneumonia, lung cancer, becoming highly dreadful because of their associated fatality. Inflammation is one of the cores and common factors of these diseases which is mainly associated with nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) activation, NF-kappa B p65 and nuclear factor of kappa light polypeptide gene enhancer in Bcells inhibitor, alpha (I kappa B alpha) phosphorylation, and initiation of the signaling pathway of the NF-kappa B. The secondary metabolites from natural sources are the active component that attenuates NF-kappa B and the associated pathway that inhibits inflammation in lung diseases. Nutraceuticals belonging to the chemical category polyphenols, alkaloids, terpenoids, flavonoids, tannins have the potential to combat the NF-kappa B pathway. Accordingly, this review discusses the medical value of nutraceuticals briefly and their ability to mitigate various inflammatory lung diseases through targeting inhibition of NF-kappa B.